4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000484
Chief Scientific Officer bought 1,799 shares at $2.28 ($4,098)
From the SEC's structured data for this filing
Trades in this filing
NEIL GARRY ARTHUR · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-10 | Purchase : show line 1 in the form | +1,799 | $2.28 | $4,098 | 74,081 | D |
| Open-market purchases · 1,799 sh · avg $2.28 · $4,098 | ||||||
Loading xslF345X03/edgar.xml…